Drugs and Devices

FDA approves drug to treat multi-drug resistant TB

On Dec. 31, 2012, the U.S. Food and Drug Administration (FDA) approved Sirturo (bedaquiline) as part of combination therapy to treat adults with multi-drug resistant pulmonary tuberculosis (TB) when other alternatives are not available. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares